USANA Health Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Common Stock And Earnings Per Share (Tables)

9 Months Ended

Oct. 01, 2016


	Quarter Ended		Nine Months Ended
	October 3,	October 1,	October 3,	October 1,
	2015	2016	2015	2016

Net earnings available to common shareholders	$ 25,609	$ 30,098	$ 70,705	$ 78,159


Weighted average common shares outstanding - basic	12,852	12,089	12,747	12,056

Dilutive effect of in-the-money equity awards	465	436	462	469

Weighted average common shares outstanding - diluted	13,317	12,525	13,209	12,525


Earnings per common share from net earnings - basic	$ 1.99	$ 2.49	$ 5.55	$ 6.48

Earnings per common share from net earnings - diluted	$ 1.92	$ 2.40	$ 5.35	$ 6.24


Equity awards for the following shares were not included in the computation of diluted EPS due to the fact that
their effect would be anti-dilutive:
	Quarter Ended		Nine Months Ended
	October 3,	October 1,	October 3,	October 1,
	2015	2016	2015	2016
	361	1,154	196	1,118